GlassScriptPhysician profile
Jeffrey Chen Lou
NPI 1679729446
$24,057.69
in general payments reported to CMS, 2019-2025
63 companies · $4,445 in 2025
The $4,445 reported for 2025 was more than what 90% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,594 · 2020: $1,715 · 2021: $3,412 · 2022: $4,230 · 2023: $3,780 · 2024: $4,881 · 2025: $4,445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $114 · Education: $99.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,893.64 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $113.99 |
| Education | $99.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $2,975.33 | 2019-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $1,958.14 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $1,701.20 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $1,277.67 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Astellas Pharma US INC | $1,220.50 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Teleflex LLC | $1,014.00 | 2021-2025 | Urolift, Barrigel, Deknatel |
| Boston Scientific Corporation | $943.47 | 2021-2025 | Rezum Generator, Greenlight Xps, Spaceoar Vue System - 10ml |
| Abbvie INC. | $929.89 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $924.63 | 2019-2024 | Xiaflex, Aveed, Edex |
| Progenics Pharmaceuticals, INC. | $876.60 | 2021-2025 | Pylarify |
| Blue Earth Diagnostics | $841.89 | 2019-2025 | Posluma |
| Urogen Pharma, INC. | $793.01 | 2020-2025 | Jelmyto |
| Pfizer INC. | $739.01 | 2019-2025 | |
| Endo USA, INC. | $689.40 | 2024-2025 | Xiaflex, Aveed |
| Antares Pharma, INC. | $645.28 | 2019-2025 | Xyosted, Tlando, Nocdurna |
Show all 63 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $472.58 | 2021-2024 | Axonics |
| Novartis Pharmaceuticals Corporation | $449.17 | 2022-2025 | |
| Amgen INC. | $443.13 | 2019-2023 | Prolia |
| Merck Sharp & Dohme LLC | $430.15 | 2020-2025 | Keytruda, Welireg, Lynparza |
| Ferring Pharmaceuticals INC. | $399.89 | 2019-2025 | Adstiladrin |
| Myovant Sciences INC. | $387.76 | 2021-2022 | |
| Clarus Therapeutics INC. | $292.83 | 2020-2021 | |
| Dornier Medtech America, INC | $289.20 | 2023 | Dornier Medtech |
| Procept Biorobotics Corporation | $262.46 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Medtronic USA, INC. | $231.18 | 2019-2020 | |
| Bioprotect Medical, INC. | $220.66 | 2024-2025 | Bioprotect Balloon Implant System |
| Astrazeneca Pharmaceuticals LP | $220.14 | 2020-2025 | Lynparza |
| Neotract INC. | $211.44 | 2020 | |
| Urovant Sciences INC | $202.00 | 2021-2022 | |
| Travere Therapeutics, INC. | $200.02 | 2019-2022 | |
| Accord Healthcare, INC. | $195.03 | 2022-2025 | |
| Rochester Medical Corporation | $155.25 | 2019-2022 | |
| Ambu INC. | $145.01 | 2023-2024 | |
| Tempus Ai, INC | $106.87 | 2024-2025 | Xt Cdx |
| Allergan, INC. | $93.06 | 2019-2021 | |
| C. R. Bard, INC. & Subsidiaries | $80.55 | 2023-2025 | Bard Urinary Drainage Bag |
| Halozyme INC | $78.77 | 2023 | |
| Tolmar Pharmaceuticals, INC. | $74.86 | 2020-2022 | |
| Ethicon US, LLC | $59.17 | 2022-2024 | Endopath Xcel, Echelon Flex, Stratafix |
| Sun Pharmaceutical Industries INC. | $57.51 | 2019-2025 | |
| Tolmar, INC. | $54.06 | 2023-2024 | |
| Foundation Medicine, INC. | $50.36 | 2021 | |
| Cycle Pharmaceuticals INC | $50.27 | 2024-2025 | Tiopronin, Venxxiva |
| Laborie Medical Technologies Corp. | $49.16 | 2025 | |
| Davol INC. | $47.38 | 2023 | Arista Ah Flexitip |
| Photocure INC | $45.95 | 2019-2021 | |
| Abc Home Medical Supply, INC. | $42.85 | 2025 | |
| Immunitybio, INC. | $42.15 | 2024-2025 | |
| Genzyme Corporation | $39.53 | 2019-2023 | |
| Coloplast Corp | $38.20 | 2024 | |
| Cardinal Health 414 LLC | $37.74 | 2022-2024 | |
| Olympus America INC. | $35.69 | 2025 | Itind System |
| Janssen Scientific Affairs, LLC | $27.71 | 2019 | |
| Myriad Genetic Laboratories, INC. | $25.83 | 2021 | |
| Metuchen Pharmaceuticals | $24.57 | 2019-2021 | |
| Clovis Oncology, INC. | $24.27 | 2020 | |
| Palette Life Sciences, INC. | $23.24 | 2023 | |
| Azurity Pharmaceuticals, INC. | $22.04 | 2025 | Azmiro |
| Mission Pharmacal Company | $21.13 | 2019 | |
| Medtronic, INC. | $19.50 | 2021 | |
| Telix Pharmaceuticals | $17.70 | 2022 | |
| Verity Pharmaceuticals INC. | $16.59 | 2023 | Trelstar |
| Kowa Pharmaceuticals America, INC. | $13.06 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Lou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.